Always pay close attention to insider buying. Most times, they’ll lead you to opportunity. Look at Constellation Energy (STZ), for example. After gapping from about $226 to a recent low of about $171, the company’s Chair paid $340,886 for 2,000 shares, paying...
Flying car stocks have taken off. And there’s still plenty of upside remaining. On June 9, we highlighted opportunity in eVTOL stock, Joby Aviation (JOBY), which traded at about $8.60. Today, it’s up to $16.73 and could easily test higher highs with a few key...
Just two weeks ago, we highlighted opportunity in Viking Therapeutics (VKTX). At the time, it traded at about $27.61 as it initiated its VANQUISH Phase 3 clinical program for VK2735, the company’s dual agonist of the glucagon-like peptide 1 (GLP-1) and...
“Keep an eye on oversold shares of Advanced Micro Devices (AMD),” we said on April 28. “After catching support around $77, the stock is now back to $96.64. From here, we’d like to see it retest $110 initially. Helping, analysts at Susquehanna are out with...
by Ian Cooper With markets still volatile, keep your portfolio protected with dividend stocks. Look at the Amplify CWP Enhanced Dividend Income ETF (DIVO), for example. With a yield of 4.73% and an expense ratio of 0.56%, the Amplify CWP Enhanced Dividend Income ETF...
Over the last few days, drones have seen considerable attention from the Trump Administration, creating a sky-high opportunity for related stocks, like AIRO Group (AIRO). AIRO is a “technologically differentiated aerospace, autonomy, and air mobility platform...
Three major crypto bills that could send Bitcoin – and related stocks -- to the moon this week. For one, there’s the CLARITY Act, which could provide a framework for the digital assets industry, including defining the roles of the Securities and Exchange Commission...
Keep an eye on beaten-down shares of Asana (ASAN). CEO Dustin Moskovitz recently purchased an additional 225,000 shares on July 8. He paid an average cost of $14.60 per share, totaling $3,285,000. He also picked up about $6.86 million worth of...
Just last week, we highlighted an opportunity in Viking Therapeutics (VKTX). At the time, it traded at about $26.50 as it initiated its VANQUISH Phase 3 clinical program for VK2735, the company’s dual agonist of the glucagon-like peptide 1 (GLP-1) and...
by Ian Cooper Always keep an eye on stock splits. While splits don’t change the value of a stock, they can serve as a positive signal. This can then lead to further liquidity and more investor interest. After all, if an attractive $500 stock were to split 10:1,...